Wu, X.; Long, X.; Ma, C.; Cheuk, Y.C.; Hu, M.; Hu, J.; Jiang, H.
Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer. Int. J. Mol. Sci. 2022, 23, 13873.
https://doi.org/10.3390/ijms232213873
AMA Style
Wu X, Long X, Ma C, Cheuk YC, Hu M, Hu J, Jiang H.
Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer. International Journal of Molecular Sciences. 2022; 23(22):13873.
https://doi.org/10.3390/ijms232213873
Chicago/Turabian Style
Wu, Xiaobo, Xingbo Long, Chenkai Ma, Yin Celeste Cheuk, Mengbo Hu, Jimeng Hu, and Haowen Jiang.
2022. "Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer" International Journal of Molecular Sciences 23, no. 22: 13873.
https://doi.org/10.3390/ijms232213873
APA Style
Wu, X., Long, X., Ma, C., Cheuk, Y. C., Hu, M., Hu, J., & Jiang, H.
(2022). Overexpression of Ubiquitin-Conjugating Enzyme E2C Is Associated with Worsened Prognosis in Prostate Cancer. International Journal of Molecular Sciences, 23(22), 13873.
https://doi.org/10.3390/ijms232213873